FGF2 and cancer: On the other hand, in the FGF-2 treated HeLa cells, overrepresentation of cancer-associated pathways such as chemotaxis, angiogenesis, cell proliferation, inflammation and apoptotic pathways was observed (Supplementary Fig. 2b), indicating different roles of FGF-2 in cancer and normal cells.